# ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19

> **NCT04604184** · PHASE2 · TERMINATED · sponsor: **Boehringer Ingelheim** · enrollment: 133 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** BI 764198
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04604184
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-11-03
- **Primary completion:** 2021-03-24
- **Final completion:** 2021-05-31
- **Target enrollment:** 133 (ACTUAL)
- **Why stopped:** Company decision
- **Last updated:** 2022-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04604184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04604184, "ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04604184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*